Women and Children's Health Research Institute (WCHRI)   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Edmonton Canada (2006)

Organization Overview

First Clinical Trial
2016
NCT04116203
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Women and Children's Health Research Institute, Canada | Women and Children's Health Research Institute (WCHRI)

Active Ingredients

Drugs in Phase 4 Trials (1)

ciprofloxacin (cipro) (1 trial)

Drugs in Phase 3 Trials (1)

ondansetron (zofran) (1 trial)

Drugs in Phase 1 Trials (2)

fish oil (Omegavan) (1 trial)

metformin (glucophage) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 3)

Gastroenteritis (Phase 3)

Lipid Metabolism Disorders (Phase 1)

Metabolic Diseases (Phase 1)

Polycystic Ovary Syndrome (Phase 1)

Syndrome (Phase 1)

Urinary Bladder, Overactive (Phase 4)

Urinary Tract Infections (Phase 4)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4